Calendar PYC Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:22 2024-05-23 am EDT			5-day change	1st Jan Change
0.12 ^AUD	+14.29%		+23.71%	+9.09%

May. 16	PYC Therapeutics Completes Dosing for Eye Disease Trial; Shares Fall 5%	MT
May. 09	Transcript : PYC Therapeutics Limited - Special Call

f4503ef0.xyNbULr4tq_X_CGknzgG2XkXEFrX-ABonFfuxBxwbYs.hXERCO2zhc6Hz2SV8XJ_tw9UIAiazGU7-A2gi2w5WLikFyIyl4vA3uWzVg~d73bcc97e3aad0e5db299c476299378c

2024-08-26	Q4 2024 Earnings Release (Projected)
2025-02-26	Q2 2025 Earnings Release (Projected)
2025-09-01	Q4 2025 Earnings Release (Projected)
2026-02-25	Q2 2026 Earnings Release (Projected)

2024-05-08 09:00 pm	Business Update Call
2024-04-25 07:32 pm	March 2024 Sales and Revenue Release - Activities Report
2024-03-19 10:35 pm	NWR VirtualHealthcare Conference
2024-03-17	Rights Issue: 1 new share @ 0.08 AUD for 4 existing shares
2024-02-29 01:35 am	Q2 2024 Earnings Release
2024-02-05	Euroz Hartleys HealthcareConference
2024-02-01 08:00 pm	Business Update Call
2024-01-25 04:30 am	December 2023 Sales and Revenue Release - Activities Report
2023-11-23 08:00 pm	Annual General Meeting
2023-11-16 08:00 pm	Business Update Call
2023-10-25	Wilsons Drug & DeviceConference
2023-10-24 06:27 pm	September 2023 Sales and Revenue Release - Activities Report
2023-10-21	Oligonucleotide Therapeutics Society Meeting
2023-10-04 09:00 pm	Business Update Call
2023-09-26 09:00 pm	Business Update Call
2023-09-11	E&P Healthcare Conference
2023-08-31 02:42 am	Q4 2023 Earnings Release
2023-07-25 07:08 pm	June 2023 Sales and Revenue Release - Activities Report
2023-07-04 10:00 pm	Shareholders Meeting
2023-06-15 09:00 pm	Business Update Call

Fiscal Period	June	2022	2023	2024
Net sales Million AUD	Released Forecast Spread	0,00	15,9 8,00 98.85%	5,33
EBITDA Million AUD	Released Forecast Spread	0,00	-22,4 -29,9 24.93%	-32,0
EBIT Million AUD	Released Forecast Spread	0,00	-23,3 -30,7 24.01%	-32,7
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	0,00	-23,4 -30,7 23.92%	-32,5
Net income Million AUD	Released Forecast Spread	-13,9	-22,8 -30,3 24.79%	-32,4
EPS AUD	Released Forecast Spread	0,00	-0,01 -0,01 12.35%	-0,01
Announcement Date		30/08/22	31/08/23	-

2024-06-30	IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
2024-07-15 01:45 am	ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24	LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 am	BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25	PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)

2024-05-21	CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
2024-05-21	EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 05:14 pm	ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 am	EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 am	BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 04:05 pm	CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14	GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 04:05 pm	NUVATION BIO INC.: Q1 2024 Earnings Release
2024-05-14 07:30 am	ABSCI CORPORATION: Q1 2024 Earnings Release
2024-05-14 01:50 am	BELITE BIO, INC: Q1 2024 Earnings Release